Mark Namchuk, Ph.D., has been appointed senior vice president of Research, Pharmaceutical and Nonclinical Development at Alkermes. Dr. Namchuk will be responsible for advancing the company’s early-stage product pipeline and will serve on the executive management team, reporting to Elliot Ehrich, M.D., senior vice president of R&D and chief medical officer.   Dr. Namchuk has 20 years of experience in integrated R&D and drug discovery, most recently serving as senior vice president and int...